FengHe Asia
Overview
FengHe Asia is a prominent investment management firm headquartered in Singapore, specializing in venture capital and hedge fund strategies. The firm leverages extensive knowledge, experience, and networks to uncover the best opportunities in rising Asia. FengHe Asia has maintained consistent track records of investment returns, reflecting its deep understanding of the Asian markets. The firm's investment approach is characterized by a disciplined portfolio construction and risk management, focusing on both public and private markets. FengHe Asia serves the needs of multiple families and institutional clients, emphasizing capital preservation and long-term value creation. Its synergistic businesses of venture capital and hedge fund provide a unique understanding of the drivers of investible markets in the region. FengHe Asia's leadership team comprises seasoned professionals with decades of experience in technology markets and investment management. The team has been instrumental in building the foundations of successful companies and has been recognized for their contributions to the investment landscape in Asia.
Investment Focus
- Accredited investors
- Institutional investors
Portfolio Companies
Reach FengHe Asia directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about FengHe Asia
What sectors does FengHe Asia invest in?
FengHe Asia invests in Technology and Healthcare, and is based in Singapore, Singapore. FengHe Asia is listed as a venture capital in the ConnectSafely investor database.
What stage does FengHe Asia invest at?
FengHe Asia backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does FengHe Asia invest in?
FengHe Asia invests across Hong Kong, Japan, Australia, Singapore, China and India.
What companies has FengHe Asia invested in?
FengHe Asia's portfolio includes WeDoctor, Huazhu Hotels Group, Focused Photonics, Jumei.com and Viva Biotech.
Last updated · Source: ConnectSafely investor database